Structures of pyrido[1,2a]pyrazinium and pyrido[1,2c][1,4]oxazinium bromides studied by 1H, 13C and 15N NMR, FTIR, X-ray and DFT methods
摘要:
2-R-Pyridines (R=CN, CH=NOH and COMe) with phenacyl bromide gave the corresponding quaternary bicyclic ring system containing one ring junction nitrogen and one extra nitrogen or oxygen atom (1-3). Their structures were confirmed by H-1, C-13 and (NMR)-N-15 spectra in DMSO-d(6) solution using 2D NMR techniques (COSY, NEOSY, HETCOR and HMBC). The structure of 1-oxo-3-phenylpyrido[1,2a]pyrazinium bromide monohydrate, 1, was unambiguously confirmed by X-ray crystallography. The crystals of 1 are monoclinic, space group P2(1)/n, with a=7.730(2) angstrom, b=14.094(3) angstrom, c=12.553(3) angstrom, beta=106.18(3)degrees, V=1311.3(5) angstrom(3) and Z=4 (at 110 K). The isolated entities of 1-3 were analyzed by the B3LYP/6-31G(d,p) level of theory in order to get information on the electrostatic interaction between the oppositely charged groups. (c) 2005 Elsevier B.V. All rights reserved.
Structures of pyrido[1,2a]pyrazinium and pyrido[1,2c][1,4]oxazinium bromides studied by 1H, 13C and 15N NMR, FTIR, X-ray and DFT methods
摘要:
2-R-Pyridines (R=CN, CH=NOH and COMe) with phenacyl bromide gave the corresponding quaternary bicyclic ring system containing one ring junction nitrogen and one extra nitrogen or oxygen atom (1-3). Their structures were confirmed by H-1, C-13 and (NMR)-N-15 spectra in DMSO-d(6) solution using 2D NMR techniques (COSY, NEOSY, HETCOR and HMBC). The structure of 1-oxo-3-phenylpyrido[1,2a]pyrazinium bromide monohydrate, 1, was unambiguously confirmed by X-ray crystallography. The crystals of 1 are monoclinic, space group P2(1)/n, with a=7.730(2) angstrom, b=14.094(3) angstrom, c=12.553(3) angstrom, beta=106.18(3)degrees, V=1311.3(5) angstrom(3) and Z=4 (at 110 K). The isolated entities of 1-3 were analyzed by the B3LYP/6-31G(d,p) level of theory in order to get information on the electrostatic interaction between the oppositely charged groups. (c) 2005 Elsevier B.V. All rights reserved.